Teva Pharma has a generic version, but earlier this year there were some consumer complaints, now the FDA has cleared another manufacturer to produce a generic version, Watson Pharmaceuticals. This is for the 150 mg dose. No word yet as to the availability from the article. BD 
CORONA, Calif., Nov. 26 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received final approval today from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets (XL) in the 150 mg strength. Bupropion Hydrochloride Extended-Release Tablets is the generic equivalent to GlaxoSmithKline's Wellbutrin XL(R) product, which is indicated for the treatment of major depressive disorder. Watson intends to launch the product immediately.
Watson Pharmaceuticals, Inc. | Investor Relations | News Release
0 comments :
Post a Comment